Myocardial infarction in diabetics

Area of Science:

• Cardiology
• Endocrinology
• Public Health

Background:

• Acute myocardial infarction (AMI) poses a significant risk to patients with diabetes mellitus.
• Understanding mortality patterns in diabetic patients post-AMI is crucial for improving clinical outcomes.

Purpose of the Study:

• To analyze hospital mortality rates and influencing factors for diabetic patients experiencing AMI.
• To evaluate the impact of coronary care unit (CCU) treatment on mortality in this population.

Main Methods:

• Retrospective analysis of 285 diabetic patients diagnosed with AMI over a decade.
• Comparison of mortality rates based on diabetes management (insulin vs. oral hypoglycaemic drugs), gender, age, diabetes duration, and retinopathy presence.
• Assessment of CCU treatment effectiveness.

Main Results:

• Overall 12-month hospital mortality for AMI in diabetics was 51%.
• CCU treatment benefited patients on oral hypoglycaemic drugs but not those on insulin.
• Female patients on oral hypoglycaemic drugs exhibited the highest mortality.
• Diabetics on oral therapy showed worse outcomes compared to insulin-treated patients when considering age, diabetes duration, and retinopathy.

Conclusions:

• AMI in diabetic patients has a high mortality rate, with limited improvement over 12 months.
• Diabetes management strategy (insulin vs. oral agents) significantly impacts AMI outcomes.
• Targeted interventions for high-risk subgroups, such as females on oral hypoglycaemic drugs, are warranted.